98%
921
2 minutes
20
Kawasaki disease (KD) is an acute self-limited febrile vasculitis that mainly affects young children. Coronary artery involvement is the most serious complication in children with KD. It is currently the leading cause of acquired cardiac disease in children from developed countries. Literature data indicate a significant role of genetic susceptibility to KD. The aim of this study was to perform the first Genome-Wide Association Study (GWAS) in a population of Polish children with KD and identify susceptible genes involved in the pathogenesis of KD. The blood samples of Kawasaki disease patients ( = 119) were collected between 2016 and 2020, isolated and stored at the Department of Pediatrics, Nutrition and Metabolic Diseases, Children's Memorial Health Institute in Warsaw. The control group was based on Polish donors ( = 6,071) registered as the POPULOUS collection at the Biobank Lab of The Department of Molecular Biophysics in University of Lodz. DNA samples were genotyped for 558,231 Single Nucleotide Polymorphisms (SNPs) using the 24 × 1 Infinium HTS Human Core Exome microarrays according to the protocol provided by the manufacturer. In order to discover and verify genetic risk-factors for KD, association analysis was carried out using PLINK 1.9. Of all 164,395 variants, 5 were shown to occur statistically (p < 0.05) more frequent in Kawasaki disease patients than in controls. Those are: rs12037447 in non-coding sequence (p = 8.329 × 10, OR = 8.697, 95% CI; 3.629-20.84) and rs146732504 in KIF25 (p = 0.007354, OR = 11.42, 95% CI; 3.79-34.43), rs151078858 in PTPRJ (p = 0.04513, OR = 8.116, 95% CI; 3.134-21.01), rs55723436 in SPECC1L (p = 0.04596, OR = 5.596, 95% CI; 2.669-11.74), rs6094136 in RPN2 (p = 0.04755, OR = 10.08, 95% CI; 3.385-30.01) genes. Polymorphisms of genes KIF25, PTRPJ, SPECC1L, RNP2 may be linked with the incidence of Kawasaki disease in Polish children.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937642 | PMC |
http://dx.doi.org/10.3389/fped.2021.624798 | DOI Listing |
Paediatr Child Health
August 2025
Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
Objectives: To determine if children with Kawasaki disease (KD) are at an increased long-term risk of cardiovascular disease and mortality.
Methods: A systematic review and meta-analysis was performed. A systematic search of MEDLINE, EMBASE, CINAHL, Cochrane, and Web of Science databases was performed through 2022.
Indian J Pediatr
September 2025
Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
Eur J Nucl Med Mol Imaging
September 2025
Advanced Neuroimaging Center, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Chiba-shi, Chiba, 263-8555, Japan.
Purpose: Astrocyte reactivation can be assessed using positron emission tomography (PET) ligands targeting monoamine oxidase B (MAO-B). C-SL25.1188 binds reversibly to MAO-B, allowing precise density measurements, but requires invasive arterial sampling.
View Article and Find Full Text PDFPediatr Res
September 2025
Kawasaki Disease Foundation Australia Inc, Melbourne, VIC, Australia.
Biochim Biophys Acta Mol Basis Dis
September 2025
Department of Clinical Biological Resource Bank, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, 510623, China. Electronic address:
Purpose: Kawasaki disease (KD) is an acute systemic vasculitis and a leading cause of acquired heart disease in children in developed countries. This study endeavors to explore the role and underlying mechanisms of EIF2AK3 in KD-related vasculitis, thereby offering novel therapeutic perspectives.
Methods: DNA from 910 KD patients and 848 controls were genotyped for rs13045 using TaqMan® to analyze the association with KD susceptibility.